Page URL:

Report on the recommendations for the future of genomic medicine released

24 May 2010
Appeared in BioNews 559

The UK's Foundation for Genomics and Population Health (PHG Foundation) has called for the Government to improve its policies for using genomic medicine to treat patients.

The report calls for the Department of Health to give general practitioners (GPs) advice on how to use genomic medicine. Central to their recommendations is that GPs know too little about genomic medicine to select the best options for patients, meaning it is not improving public health.

Speaking to The Times newspaper, Caroline Wright, head of science at the PHG Foundation, explained the concern: 'There's an implicit assumption that testing is good, that knowledge is power, but the key question is does a test result helpfully change the management of a patient? If not, it is a waste of money'.

'When public money is being spent, it must be spent sensibly to get better care outcomes. It's really important that anything funded by health systems has evidence behind it'.

The report's other recommendations include the development of improved biomedical informatics systems and IT infrastructure; better guidance on who can access and use genomic data; improving public awareness of genomics; and developing Europe-wide regulations for genetic tests.

In total, the report makes twelve recommendations 'to realise the benefits of genomic science for health, wealth and society'.

Produced in collaboration with the University of Cambridge's Centre for Science and Policy (CSaP), the report was developed in response to the House of Lords Committee on Science and Technology's 2009 Report on Genomic Medicine.

This concluded genomics would play a major role in the treatment of complex conditions, such as cancer. But the PHG report found - in the short term - that the greatest benefits of genomic medicine would be in diagnosing single gene disorders.

Experts call for prompt, realistic approach to genomic medicine
PHG Foundation |  18 May 2010
Experts call for UK Government to prioritise immediate benefits of genomic medicine over more remote possibilities
Press Release-PHG Foundation |  18 May 2010
Potential of genomic medicine could be lost, say science think-tanks
The Times |  17 May 2010
12 July 2010 - by Dr Vivienne Raper 
Before Dr Julian Huppert was elected MP for Cambridge in May this year, he was a computational biologist at Cambridge University studying the structure and function of DNA. Now, he's one of only two scientists with PhDs in parliament. BioNews quizzed him about science funding, synthetic biology and the shortage of scientists in politics...
4 May 2010 - by Dr Sophie Pryor 
Whole genome analysis has been used for the first time to gather clinically-useful information about the risk of developing diseases later in life. Stephen Quake, an apparently healthy, middle-aged professor of bioengineering at Stanford University in California, volunteered to have his entire genetic code screened. He was found to be at increased risk of developing diabetes, some cancers and of having a heart attack...
7 January 2010 - by MacKenna Roberts 
The contemporary media is increasingly flooded with stories where the cause, explanation or hope involves genetics. With all the reporting of genetic findings and its 'potential' to improve clinical care - has genetics really led to a marked improvement in our healthcare? And should genetic determinism be the focus of scientific research?...
7 December 2009 - by Antony Starza-Allen 
As our understanding of genetics and associated disorders has developed, many genetic tests performing functions - from predicting certain genetic predispositions and identifying rare monogenetic disorders, to ancestry and other 'novelty' tests - have been introduced to the healthcare market. Many geneticists are concerned about the regulation of these tests, which are performed by the NHS, the private sector, or distributed directly to consumers. Experts are calling for more transparent eval...
5 October 2009 - by Sarah Pritchard 
Genome sequencing is changing its approach to focus more on rare conditions affecting individuals instead of common population-wide diseases. Scientists are abandoning genome-wide association studies (GWAS) which focus on DNA analysis of common diseases and which have been the aim of genomics research in the last decade. They are instead returning to study rare disorders which are traceable to defects in single genes....
19 July 2009 - by Dr Rob Elles 
Since 2003, the framework for policy in Genetics in Medicine in the UK has been the Genetic White Paper 'Our Inheritance Our future.' There is no doubt that its implementation helped modernise and broaden the scope of genetics in the National Health Service (NHS). It developed new support structures including the National Genetics Education Development Centre and the National Genetic Reference Laboratories, and established the (short lived) Genetic Knowledge Parks....
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.